SCHEMBL7796793

SCHEMBL7796793

CC(=O)Oc1ccc2[nH]c(-c3ccc(O)c(C45CC6CC(CC(C6)C4)C5)c3)nc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 7/20 0.47
RARA P10276 6/20 0.47
RARG P13631 6/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
ALOX12 P18054 1/20 0.47
MAPK1 P28482 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSD17B10 Q99714 1/20 0.47
IKBKB O14920 2/20 0.42
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7047540 0.93 RARB (0.50) RARBRARARARGMEN1KMT2A
SCHEMBL7796798 0.92 RARB (0.47) RARBRARARARGMEN1KMT2A
SCHEMBL7786948 0.90 RARB (0.44) RARBRARARARGMEN1KMT2A
SCHEMBL7795164 0.88 MEN1 (0.45) RARBRARARARGMEN1KMT2A
SCHEMBL6571495 0.83 RARA (0.54) RARBRARARARGMEN1KMT2A
SCHEMBL7786953 0.83 AMY1A (0.50) RARBRARARARGMEN1KMT2A
SCHEMBL7786883 0.82 RARB (0.46) RARBRARARARGMEN1KMT2A
SCHEMBL7052839 0.82 RARG (0.64) RARBRARARARGMEN1KMT2A
SCHEMBL7795169 0.80 TP53 (0.52) RARBRARARARGMEN1KMT2A
SCHEMBL9286338 0.79 SMN1; SMN2 (0.47) RARBRARARARGMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0643701-B1 BENZIMIDAZOLE-DERIVED COMPOUNDS, METHOD FOR PREPARING SAME, AND THERAPEUTICAL AND COSMETIC USES THEREOF CT INTERNAT DE RECH S BR DERMA (FR) 2001-12-05 EP claimed
US-5446059-A Treating or preventing inflammatory or immunoallergic conditions CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1995-08-29 US claimed
EP-0643701-B1 BENZIMIDAZOLE-DERIVED COMPOUNDS, METHOD FOR PREPARING SAME, AND THERAPEUTICAL AND COSMETIC USES THEREOF CT INTERNAT DE RECH S BR DERMA (FR) 2001-12-05 EP disclosed
US-5446059-A Treating or preventing inflammatory or immunoallergic conditions CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1995-08-29 US disclosed